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The number of volatile organic compounds (VOCs) that can be purged from human blood is 
so great that they cannot be separated completely by capillary gas chromatography. As a 
result, the single-mass chromatograms used for quantitating the target compounds by mass 
spectrometry have many interferences at nominal (integer) mass resolution of a quadrupole 
mass spectrometer. The results of these interferences range from small errors in quantitation 
to completely erroneous results for the target VOCs. By using a magnetic sector mass 
spectrometer, these interferences at nominal mass can be removed at higher resolution by 
lowering the ion chromatogram windows around the masses of interest. At 3000 resolution 
(10% valley definition), unique single-ion chromatograms can be made for the quantitation 
ions of the target VOCs. Full-scan mass data are required to allow the identification of 
unknown compounds purged from the blood. By using isotope-dilution mass spectrometry, 
most target VOCs can be detected in the low parts per trilliog range for a lo-mL quantity of 
blood from which the VOCs have been removed by a purge-and-trap method. (J Am Sot Muss 
Spectrom 1992, 3, 831-841) 
T he exposure of people today to the volatile or- ganic compounds (VOCs> present in the environ- ment is of great concern in the public health field 
[l, 21. The role of drinking water as a source of VOCs 
has been studied in recent years [3-71 as have the 
presence and sources of VOCs in indoor air [8-111. 
Although the average body burden of VOCs in the 
general population is uncertain, it must be determined 
if researchers are to construct a baseline for accessing 
the occurrence and degree of exposure to VOCs. Many 
researchers have measured the body burden of VoCs 
by VOC levels in breath [12-141. However, results of 
comparative studies of breath and blood as the medium 
for body burden measurements for VOCs indicate that 
blood should yield more reliable values [15-171. Sev- 
eral studies of VOCs in human blood have been re- 
ported in which a purge-and-trap analysis was used 
together with a gas chromatograph and a quadrupole 
mass spectrometer [ 18, 191. Generally investigators 
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using these methods have reported detection limits in 
blood in the parts per billion (ppb) to high parts per 
trillion (ppt) range, which is not sensitive enough to 
assess the body burden of many VOCs among unex- 
posed persons in the general population. 
Human blood was chosen as the analytic medium 
for the measurement of VOC levels in a reference 
population, which is part of the current Third National 
Health and Nutrition Examination Survey (NHANES 
III). The NHANES IIl survey is the first national study 
to measure levels of VOCs in the population. Previ- 
ously, blood had been used in the earlier national 
surveys (NHANES I and NHANES II) to measure 
levels of metabolic elements and vitamins and also in 
NHANES II to measure the levels of pesticide residues 
[20-Z!]. Our choices of analytical procedures were 
circumscribed by the fact that the protocol of the 
NHANES III study would provide only one lo-mL 
sample of blood for each subject for the measurement 
of VOCs. The NHANES III protocol required us to 
determine the blood levels of the metabolic products 
acetone, carbon disulfide, and 2-butanone as well as a 
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number of volatile priority pollutants for each sample. 
For this study we needed a method with a large 
dynamic range that could yield low parts per trillion 
detection limits for the VOCs such as chloroform and 
methylene chloride and handle the high levels of 
metabolic products such as acetone, which is present 
commonly at low parts per million levels. Also the 
NHANES III protocol required each sample to be 
searched for nontarget compounds that might prove to 
be of interest in the future. For NHANES III, we 
developed a method for measuring more than 30 VOCs 
in a lo-mL sample of human blood by combining 
purge-and-trap isolation and concentration of the VOCs 
with capillary gas chromatography and medium reso- 
lution magnetic sector mass spectrometry, using an 
isotope dilution method. Because the identification of 
unknown compounds was required for this study, full 
scan mass data were used instead of a selected-ion- 
monitoring method to give us the maximum amount 
of information for each sample. The problem of coelut- 
ing compounds with ions having the same nominal 
mass was solved by using a magnetic sector mass 
spectrometer with its higher mass resolution instead of 
a quadrupole mass spectrometer that could yield only 
nominal (integer) mass resolution. We achieved a bal- 
ance of high sensitivity versus mass discrimination by 
operating the mass spectrometer at 3000 resolution 
(10% valley definition). Most target VOCs could be 
detected by our method in the low parts per trillion 
range for a IO-mL sample of whole blood. 
Experimental 
Instrumental Analysis 
The analytic system developed for the VOC analysis 
consists of a purge-and-trap system interfaced to a gas 
chromatograph with a capillary chromatography col- 
umn connected directly to the ion source of a magnetic 
sector mass spectrometer. 
The purge-and-trap system made by Tekmar Co. 
(Cincinnati, OH) consists of a LSC 2000 purge-and-trap 
concentrator coupled to an ALS 2016 automatic sam- 
pler, an automatic sample heating unit, and a capillary 
interface that allows on-column cryofocusing. A heated, 
fused silica transfer line from the LSC 2000 unit was 
connected directly to the capillary chromatography 
column by a gold-plated union above the cryofocus 
zone inside the capillary interface. Research-grade he- 
lium was used for both purge gas and gas chromatog- 
raphy carrier gas. A flow meter was attached to the 
vent port of the LSC 2000 unit to monitor the purge 
flow rate, because the rate was found to vary by as 
much as 10 mL/min among the sparger ports for the 
same setting of the flow needle valve. Purge flow rate 
was maintained at 30 mL/min at 20 psi, which was 
essential to prevent trap breakthrough. Glass-lined 
tubing and fused silica transfer lines were used for all 
sample paths for inertness. The internal valves, metal 
unions, and transfer lines were heated at 100 “C. The 
25-mL glass tube needle spargers used for samples 
were heated by individual heating jackets. Each run 
began with a 3-min heating cycle at 30 “C to ensure 
uniformity. The samples were then purged with he- 
lium for 15 min at 30 “C, during which time the VOCs 
were trapped on a Tenax trap (Tenax packed in a 0.125 
in X 12 in stainless steel tube from Tekmar Co.). This 
trap was then dry purged with helium for 6 min. The 
VOCs were desorbed by heating the trap at 180 “C for 
4 min and then trapped and refocused at the head of a 
capillary chromatography column by cryogenic cooling 
at ~ 150 “C with liquid nitrogen. The cold-trapped 
VOCs were vaporized by being heated at 200 “C for 
0.75 min. Finally the trap was baked at 225 “C for 36 
min. 
Chromatography was performed with a Hewlett- 
Packard (Avondale, PA) 5890 gas chromatograph (GC) 
with subambient liquid nitrogen valve. The column 
was a DB-624 (J & W Scientific, Folsom, CA) 30 m X 
0.32 mm, with a 1.8-pm film thickness. The carrier gas 
was helium at 5-psi head pressure and I-mL/min 
flow. The column was run directly from the union in 
the Tekmar capillary interface through the injection 
heater (heated at 200 “C) and the oven of the GC to the 
ion source block of the mass spectrometer. A heated 
interface controlled by the mass spectrometer at about 
200 “C joined the GC oven with the mass spectrometer. 
The GC temperature program consisted of the follow- 
ing sequence: initial hold at 0 “C for 1.5 min, ramp at 
12 “C/min for 2.5 min, hold at 30 “C for 2 min, ramp at 
8 “C/min for 20 min, and hold at 190 “C for 10 min. 
Total run time from helium purging to the return to 
initial conditions was about 70 min. 
Compound identification was made with full-scan 
data from a VG 7070E (VG Analytical Ltd., Man- 
chester, UK) double-focusing magnetic sector mass 
spectrometer by electron ionization at an electron en- 
ergy of 70 eV. The mass spectrometer was scanned 
exponentially from 190 down to 34 Da in the current 
mode at 1 set/decade and with a magnet settling time 
of 0.20 set, which gave a scan cycle time of 0.92 sec. 
The instrument functions and data collection were 
controlled by a VG 11-250J data system consisting of a 
Digital PDP11/73 computer with a DEC RD53 disk 
drive and a DEC TK50 tape system (Digital Equipment 
Corp., Maynard, MA). 
The mass spectrometer was tuned and calibrated 
with perfluorokerosene (PFK) at 3000 resolution (10% 
valley definition) before each run, and then the PFK 
was pumped away. The removal of the PFK was 
necessary because its ions of m/z 99.9936 and 111.9936 
could not be separated at 3000 resolution from the 
quantitation ions of some VOCs such as [2H,l-l,l,l-tri- 
chloroethane and chlorobenzene. The VG calibration 
program was used to generate a calibration file from 
the PFK run by using three lockmasses (m/z 168.9888, 
130.9920, and 118.9920) and a primary reference file of 
PFK. For each scanning acquisition, the mass-peak 
times were stored and an empty subfile was created 
for mass data so that afterwards the experimental 
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calibration file could be used with a VG mass meas- 
urement program to calculate accurate masses for the 
run. After each run, the stability and accuracy of the 
mass scale were checked by calculating the accurate 
masses for a set of compounds spanning both ranges in 
mass and elution time: [r3C]chloroform, [r3C,]benzene, 
[2 H,,]ethylbenzene, [‘3C]bromoform, and naphthalene 
(Table 1). The data for a typical blood sample of the 
NHANES III study (a 9.59-g sample of blood spiked 
with internal standard solution), given in Table 1, 
show that the mass scale is reasonably stable over the 
time scale of each GC peak and over the duration of 
the analytical run. To be acceptable, the absolute value 
of maximum deviation from theoretical mass should 
be less than 0.025 Da in all cases. Usually the deviation 
was much less even though there was a half-hour 
delay between the PFK calibration and the start of data 
acquisition. The mass scale stability was sufficiently 
good to allow the automated generation of mass chro- 
matograms from the theoretical masses with a mass 
window of 0.03 Da over the entire GC run. The signal- 
to-noise ratios for this sample of blood are typical of 
the usual run (analyte (quantitation ion, concentration, 
S/N ratio)): [13C]chloroform (13CHC1;, 80 ppt, 30/l), 
[%,]benzene (13C,Hi; 180 ppt, 100/l), [‘H,,]ethyl- 
benzene (CiH&, 350 ppt, 100/l), and [‘3C]bromoform 
(13CH79BrR’Br+, 500 ppt, 30/l). 
The necessity of using higher mass resolution for 
the blood samples dictated the choice of a magnetic 
sector mass spectrometer over a quadrupole mass 
spectrometer with its nominal (unit) mass resolution. 
A resolution of 3000 was chosen for the full-scan data 
to achieve the greatest mass discrimination consistent 
with a sensitivity in the low parts per trillion range for 
most of the target VOCs. A resolution of 3000 was the 
best compromise under our experimental constraints 
of one lo-mL sample of blood per individual and the 
need to use full-scan data. For full-scan spectra at 3000 
resolution, signal-to-noise ratios of 3/l to 5/l were 
achievable at the detection limits of many target VOCs 
for a lo-mL blood sample with our VG 7070E mass 
spectrometer. Because we had to use full-scan data, an 
increase of mass resolution above 3000 caused an ur- 
acceptable decrease in signal intensity. Because we 
must be able to handle any nontarget compounds that 
might be present in the blood samples, we need to be 
able to form unique mass chromatograms for the 
greater majority of possible volatile compounds. The 
ability to form unique mass chromatograms for ace- 
tonitrile and Z-propanol, which form a merged GC 
peak in many blood samples, was judged to be consist- 
ent with the required mass discrimination. The molec- 
ular ion C2H3Nf’ (m/z 41.0265) of acetonitrile is just 
separable from the C,H: ion (m/z 41.0391) of 2- 
propanol at 3000 resolution. 
Full-scan data were needed for this study because 
of the requirement to search for and identify all non- 
target compounds that might be purged from the blood 
samples, some of which compounds might possibly be 
found to be harmful in the future. A full-scan mass 
spectral library of target VOCs and their labeled 
analogs was created from standards run under our 
experimental conditions. The positive identification of 
a target VOC or labeled analog was based on a match 
of its full-scan mass spectrum with the corresponding 
full-scan mass spectrum of a standard in our user 
library. The minimum requirement for compound de- 
tection was that the quantitation ion and one addi- 
tional major ion of the compound must be present in at 
least two consecutive scans in its retention time win- 
dow and qualitatively have a similar intensity ratio to 
that found in the standard mass spectrum in our user 
library. The retention time window of each target VOC 
is a five-scan interval determined relative to its own 
labeled analog. 
The method validation and data processing for the 
analysis of the VOCs are discussed elsewhere [23]. 
Sample Preparation 
Human blood samples were collected as part of the 
Third National Health and Nutrition Examination Sur- 
vey. The blood was drawn in lo-mL portions by Grey- 
Top vacutainers containing solid potassium oxalate 
and sodium fluoride (Becton Dickinson, Rutherford, 
NJ), which were specially processed in our laboratory 
to remove VOC contamination resulting mainly from 
the rubber stopper. The vacutainers were disassembled 
and the glass tubes and rubber stoppers were heated 
for 2 weeks at 70 “C, under vacuum. After being 
Table 1. Typical mass scale stability over the duration of GC-MS run for a blood sample” 
Retention 
time Scans Experimental Deviation from 
Analyte (mini in peak mean mass + S.D. theoretical massb 
I’3C1Chloroform 9.07 7 83.9404 f 0.0013 - 0.0085 + 0.0013 
P3C IBenzene 
12ti,~~EChyIbenzene 
9.93 9 84.0594 f 0.0017 -0.0077 x+z 0.0017 
15.93 9 116.1325 k 0.0030 -0.0085 + 0.0030 
I’3C1Bromoform 17.20 7 173.8355 + 0.0014 -0.0103 * 0.0014 
Naphthalene 24.28 9 128.0538 & 0.0016 -0.0088 f 0.0016 
‘The experimental data are for a 9.59-g sample of whole human blood spiked with inter,~al standard 
solution. Single-mass chromatograms from this sample of blood are shown in Figures 1, 2, and 3. 
bThe theoretical rnas~es are the following: [‘3Clchloroform, 83.9469: [‘3CBlbenzene. 84.0671; 
IZH,,lethylbenzene, 116 1410; [‘3Clbramofarm, 173.8458: naphthalene, 128.0626. 
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reassembled, the vacutainers were evacuated and then 
sterilized using a cobalt-60 gamma ray source. The 
blood was cooled and shipped refrigerated to this 
laboratory and then stored at 4 “C. Before analysis, the 
blood was removed from refrigeration and gently 
remixed by a hematology mixer. The blood was with- 
drawn from the vacutainers by piercing the septum 
with a disposable l-inch 18 gauge stainless steel needle 
attached to a glass Hamilton lo-mL gas-tight syringe 
with a Luer tip. After the needle was removed, 20 PL 
of internal standard solution in methanol was added 
directly to the blood in the syringe by an SMI 
Micro/Petter (American Hospital Supply Corp., 
Miami, FL) with a disposable glass capillary tube; this 
procedure was used for all types of samples. After the 
syringe was attached to a sparger valve on the purge- 
and-trap system, the blood was injected into a glass 
tube sparger, containing small chips of solid antifoam 
8. The solid antifoam B was prepared in this labora- 
tory from an aqueous emulsion of antifoam B (Sigma 
Chemical Co., St. Louis, MO) by room temperature 
evaporation at atmospheric pressure. 
Human serum was used for quality control in this 
study. The serum had to be purged overnight with 
research-grade helium to produce a virtually volatile- 
free material. Two batches of serum were prepared 
at two spiking levels of native analytes and then 
stored in the dark at - 60 “C in lo-mL portions in glass 
serum bottles (Wheaton Scientific, Millville, NJ) with 
Teflon-faced septa. Each day, a serum quality control 
sample was removed and allowed to thaw at room 
temperature. 
Standard native compounds were purchased from 
Aldrich Chemical Co. (Milwaukee, WI) or Burdick and 
Jackson (Muskegon, MI). lsotopically labeled analogs 
were purchased as neat compounds from Cambridge 
Isotope Laboratories, Inc. (Wobum, MA) or from 
Merck, Sharp, and Dohme/Isotopes (St. Louis, MO). 
Stock solutions were prepared in methanol (purge and 
trap grade from Burdick and Jackson) and were trans- 
ferred to and sealed in small glass ampoules, which 
were then stored in the dark at -60 “C. The internal 
standard solution in methanol and a water standard of 
native analytes in “VOC-free” water were prepared 
fresh each day. Samples of “VOC-free” water (contain- 
ing < 20 ppt of most VOCs) were prepared by helium 
purging of rural well water at elevated temperature 
followed by distillation under helium purge, using a 
similar method to that reported previously [24]. 
ing techniques depends on its interactions with the 
various components of the blood matrix such as lipids, 
proteins, water, salts, and blood cells. These matrix 
interactions tend to be highly specific for different 
compounds. To minimize the matrix effects on analyte 
recovery, it is essential to use an isotopically labeled 
analog of an analyte as the internal standard because 
the labeled analog should closely mimic the behavior 
of the analyte in the blood. As one pushes the detec- 
tion limits for VOCs in blood to the low parts per 
trillion level, the use of isotopically labeled analogs 
becomes critical to quantitative accuracy. 
The 35 VOCs that were measured in blood were 
referenced against 33 labeled internal standards. Only 
two VOCs have no labeled analog as an internal stand- 
ard. The 1,3-dichlorobenzene is referenced against 
[2H,]-1,4-dichlorobenzene. On the DB-624 column, m- 
xylene and p-xylene coelute and are reported as a 
composite amount, which is referenced against [’ H,,]- 
p-xylene. The relative retention times for the analytes 
and internal standards calculated against [‘H,]toluene 
are given in Table 2 for the DB-624 column under our 
experimental conditions. The retention times were used 
to establish the set of retention time windows used for 
automatic area determination of the mass chro- 
matograms used for quantitative analysis. The accu- 
rate masses and chemical formulae of the quantitation 
ions for these compounds are listed in Table 3. Because 
we are using full-scan data, we generate a single-ion 
chromatogram by using the theoretical mass of the 
quantitation ion with a limited mass window of 0.03 
Da from the full-scan data. These single-ion chro- 
matograms are used for quantitation. For [‘H1$1,2- 
dichloroethane, dibromochloromethane, and [ C]di- 
bromochloromethane, the “quantitation ion” at 3000 
mass resolution is a pair of unresolved ions, respec- 
tively: C27C12H; (m/t 67.0082) and Cz5C12H; (m/z 
67.0256); CH37C179Br’ (?n/z 128.8921) and 
CH”“Cl”Br* (m/z 128.8930); ‘“CH’7C179Br+ (m/z 
129.8954) and 13CH”“ClX’Br+ (nr/z 129.8963). For each 
pair of ions, an intermediate mass is used with the 
limited mass window to construct a suecific mass 
chromatogram that includes the mass sig;als for both 
of the unresolved ions. The quantitation ions are only 
used in the quantitative procedure; compound identi- 
fication depends on the full-scan mass spectral match 
of the compound with a corresponding mass spectrum 
of a standard in our user library. 
The choices of quantitation ions for the metabolic 
products acetone, carbon disulfide, and 2-butanone 
were dictated by their high concentrations in the blood, 
which usually range from the high parts per billion 
level to the low parts per million level. For acetone 
both the base peak C,H,O+ (m/z 43.0189) and the 
molecular ion C,H,O+- (m/z 58.0419) are saturated 
Results and Discussion 
Chromatography and Isotope-Dilution Mass 
Spectrometry 
” 
Isotope-dilution mass spectrometry was used here to signals at the giin and voltage levels of the mass 
quantitate volatile organics from biological media ac- spectrometer that are required to achieve low parts per 
cording to previously described methods [25]. The trillion detection levels in the blood for the priority 
recovery of a VOC from whole blood by helium purg- pollutants such as chloroform and methylene chloride. 
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Table 2. Relative GC retention times (relative to [* H&oluene) on DE&24 capillary column 
for target VOCs and their labeled internal standards 
Relative retention Internal standard Relative retention 
Target VOCs (natives) timea R = native time0 
1 ,I -Dichloroethene 0.367 [2H,lR 0.366 
Acetone 0.383 PC,1R 0.384 
Carbon disulfide 0.387 [“CIR 0.386 
Bromoethane 0.390 [=ClR 0.390 
Methylene chloride 0.446 [13C1R 0.446 
Wan+1,2-Dichloroethene 0.488 I*H,lR 0.486 
hexane 0.538 12H&! 0.515 
1,l -Dichloroethane 0.551 ?H,IR 0.546 
cis-1,2-Dichloroethene 0.835 [‘H,lR 0.632 
2-Butanone 0.642 [4-‘H,lR 0.637 
Chloroform 0.664 [‘3 CIR 0.684 
l,l,l-Trichloroethane 0.702 ?H,lR 0.695 
Carbon tetrachloride 0.724 [I3 CIR 0.724 
Benzene 0.751 [“C,lR 0.751 
1,2-Dichloroethane 0.754 ?H,lR 0.745 
Trichloroethene 0.840 [13 CIR 0.840 
1,2-Dichloropropane 0.866 [‘H,lR 0.855 
Dibromomethane 0.881 PHJR 0.877 
Bromodichloromethane 0.906 [=ClR 0.906 
Toluene 1.009 [‘H,lR 1 Do0 
1 ,1.2-Trichloroethane 1.062 [‘H,lR 1.057 
Tetrachloroethene 1.062 [‘sClR 1.081 
Dibromochloromethane 1.113 [=ClR 1.113 
Chlorobenzene 1.195 [*H,]R 1.192 
Ethylbenzene 1.214 I’H,,IR 1.204 
m-/p-Xylene 1.231 I*H,,+R 1.220 
o-Xylem+ 1.285 I’sC IR 1.284 
Styrene 1.287 [‘H,;R 1.281 
Bromoform 1.307 [=ClR 1.309 
1 ,1,2,2-Tefrachloroethane 1.380 [‘HJR 1.378 
1.3.Dichlorobenzene 1.512 b 
1,4-Dichlorobenzene 1.525 [‘H,IR 1.523 
1.2.Dichlorobenzene 1.577 [‘H,lR 1.575 
Hexachloroethane 1.615 Ii3C1R 1.616 
*The average retention time for [2H,holuene is 13.25 + 0.02 min. The relative retention times 
calculated against [2H&luene are average values for 12 runs of standard water solutions by using our 
pyge-and-trap/GO method. The standard deviation of each relative retention time is 0.001. 
Internal standard for 1.3.dichlorobenzene is [‘H&l .4-dichlorobenzene. 
The naturally occurring carbon-13 species 13CCzH60+’ 
(m/z 59.0452) was chosen as the quantitation ion for 
acetone because its signal level usually ranged be- 
tween 20 and 80% of the signal saturation level for the 
average blood sample. For similar reasons, a less-in- 
tense ion of the mass spectrum was chosen for the 
quantitation ion for both carbon disulfide (CS%S+; 
m/z 77.9399) and 2-butanone (C4H80t; M/Z 72.0575). 
The choice of these less-intense ions is the best com- 
promise available that allows us to measure simultane- 
ously parts per trillion levels of VOCs and the much 
higher levels of metabolic products. The protocol of 
the NHANES III survey required us to measure these 
metabolic products. 
The use of the medium mass resolution of 3000 
presented us with mass interferences that we had to 
solve without recourse to even higher resolution. 
Quantitation ions for each native analyte and its la- 
beled analog were chosen to minimize the contribution 
of the native analyte to the detection of the labeled 
analog and vice versa, if the chromatographic separa- 
tion of the pair was incomplete. When a deuterated 
internal standard is used, one must often choose a less 
intense ion in order to minimize the interference be- 
tween the native and labeled pair. One example is 
[2H,]-l,l-dichloroetheneand l,l-dichloroethene, which 
elute within 3 seconds of erch other on the DB-624 
column. At 3000 resolution their more intense common 
836 BONIN ET AL. J Am Sot Mass Spectrom 1992,3,831-841 
Table 3. The quantitation ions for target VOCs and their labeled internal standards listed 
in order of increasing GC retention time (see Table 2) 
Quantrtation ion Internal standard Ouantitation ion 
Target VOCs Inatives) m /z Formulas R = native m /z Formulaa 
1 ,l -Dichloroethene 
Acetone 
Carbon disulfide 
Bromoethane 
Methylene chloride 
trans.1,2_Dichloroethene 
Hexane 
1 ,I -Dichloroethane 
c&-l ,2-Dichloroethene 
2.Butanone 
Chloroform 
1 ,l .l -Trichloroethane 
Carbon tetrachloride 
Benzene 
1,2-Dichloroethane 
Trichloroethene 
1 .ZDichloropropane 
Dibromomethane 
Bromodichloromethane 
Toluene 
1 ,l &Trichloroethane 
Tetrachloroethene 
Dibromochloramethane 
Chlorobenzene 
Ethylbenzene 
m-/p-Xylene 
o-Xylene 
Styrene 
Bromoform 
95.9534 C,H,CI, 
59.0452 ‘3CC,Hp0 
77.9399 cs3“s 
107.9575 CzHz9Br 
83.9534 CH,CI, 
95.9534 C2H,CI, 
86.1096 CsH,4 
63.0001 CzH,CI 
95.9534 C,H,CI, 
72.0575 C,H,O 
82.9455 CHCI, 
96.9612 C,H,CI, 
116.9066 Ccl, 
78.0470 C,H, 
61.9923 C,H,CI 
129.9144 &HCI, 
63.0002 C,H,CI 
171.8523 CH:‘Br 2 
82.9455 CHCI, 
91.0548 C,H, 
96.9612 C,H,CI, 
165.8725 C37CICI 2 3 
128.8923 ’ 
112.0080 C,H,CI 
106 0783 C,H,, 
106.0783 C,H,, 
106.0783 C,H,, 
104.0626 C,H, 
272.8425 CH79Brs’Br 
1 ,I .2.2-Tetrachloroethane 82.9455 CHCI, 
1,3-Dichlorobanzene 145 9690 C,H,CI, 
1,4-Dichlorobenzene 145.9690 C,H,CI, 
1.2.Dichlorobenzene 145.9690 C,H,CI, 
Hexachloroethane 165.8725 C:‘CICI 3 
[‘H,lR 
PC IA 
&R 
PCIR 
PCIFI 
[*H,lR 
[2H,,1R 
[*H,lR 
[“H,lR 
W*H,lR 
[=ClR 
[“H31R 
[13C1R 
[=C IR 
[“H,YR 
[=ClR 
[‘H,lR 
?H,lR 
[‘3C1R 
[‘H,lR 
?H,lR 
t3ClR 
I=ClR 
12HSlR 
12~,,1~ 
IZH,,,lp-R 
I=C IR 
12H3R 
I= CIR 
12H21R 
B 
64.9941 C,37C12H, 
61.0519 =C,H,O 
78.9433 ‘3c34ss 
110.9588 =CCH:‘Br 
84.9567 =CH,CI, 
64.9941 C;‘CI’H 2 
100.1974 C;H,, 
66.0189 C,HCl’H, 
64.9941 C;‘CIZH 2 
75.0764 C,H:HJO 
83.9489 ‘3CHCI, 
99.9800 C,CI:H, 
117.9099 ‘?CI, 
84.0671 =C,H, 
67.0169 b 
130.9177 ‘3CCHCI, 
67.0253 C,Ci’H, 
177.8608 C*H;‘Br 
’ 83.9489 -CHCI, 
98.0987 C:H, 
99.9800 C,CI$H, 
166.8758 =cc~‘cIcI 3 
129.8958 d 
117.0394 C,CI’H, 
116.1410 C;H,o 
116.1410 C:H,o 
108.0850 ‘3C,C,H,, 
112.1128 CjH, 
173.8458 ‘3CH79Br8’Br 
83.9518 CCI$H 
?H,lR 151.9912 C;‘CICl’H 4 
[‘H,lR 151.9912 C;‘CIC12H 4 
t=ClR 166.8758 ‘3cc3’cIcI 3 
aThe symbols for chemical elements wlthout a mass number stand for the mosf abundant naturally 
accurring isotope. All ions are positive. 
b Mass between ‘hat of unresolved ions Cz7C12H$ and C~6C12H$. 
‘Mass between that of unresolved ions CH37C179Br ’ and CH3’C18’Br+. 
dMass between that of unresolved ions ‘3CH37C179Br+ and ‘3C35CIB’Br+. 
‘Internal standard for 1.3.d~chlorobenzene IS [ZH4]~1,4~dichlorobenrene 
ions at nominal mass (98, 100, 61, and 63 Da) cannot be 
separated by using enhanced resolution. The only 
unique ions with enough intensity to be useful are 
C,Hz5C11 at m/z 95.9534 for l,l-dichloroethene and 
C2H”7Cl* at m/z 64.9941 for [2 H,]-l,l-dichloro- 
et2heie, the intensities of which are, respectively, 80 
and 30% of their base peaks. Similar problems with 
coelution and common ions determine the choice of 
the quantitation ions for the cis-1,2-dichloroethene, 
fruns-1,2-dichloroethene, 1,4-dichlorobenzene, 1,2-di- 
chlorobenzene, and their deuterated analogs. On the 
DB-624 column, o-xylene and styrene elute within 3 
set of each other and pose another common ion prob- 
lem. The loss of two hydrogens from o-xylene’s molec- 
ular ‘on, C,H& produces a low-intensity ion with the 
same molecular formula as the molecular ion of 
styrene, C,Hf , which is the base peak for styrene. 
Even styrene’s next most intense ion C,HG is common 
to o-xylene. To achieve the greatest sensitivity for 
styrene, one must use its molecular ion for the quanti- 
tation ion and correct for the contribution of any o- 
xylene. The use of carbon-13-labeled internal standards 
produces coeluting GC peaks for each native analyte 
and its carbon-13-labeled analog. Therefore, the natu- 
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ral abundance of carbon-13 in the ions of native VOCs 
must be taken into account when the single-ion chro- 
matograms are analyzed. The use of multilabeled car- 
bon-13 analogs can help minimize this interference. 
For quantitation one must correct for the contribu- 
tion of the labeled analog to the quantitation mass of 
the analyte and vice versa using native and label mass 
ratios that are independently determined by experi- 
ment. The native mass ratio, R,, is determined from a 
concentrated water standard solution without any in- 
ternal standard. R, is calculated by dividing the area 
of the analyte quantitation ion signal at the analyte 
retention time by the area of the analyte contribution 
to the analog quantitation ion at the analyte retention 
time. The label mass ratio, R,, is determined from a 
blank water sample containing a high concentration of 
the internal standard. R is calculated by dividing the 
area of the analog contra utron to the analyte quantita- .g . 
tion ion signal at the analog retention time by the area 
of the analog quantitation ion signal at the analog 
retention time. For a standard or unknown sample, the 
analyte-to-analog ratio, R,, is determined by dividing 
the area of the analyte quantitation ion signal at the 
analyte retention time by the area of the analog quanti- 
tation ion signal at the analog retention time. The 
relative response factor, RR, for an analyte is calcu- 
lated using the equation 
I==(R,-R,)(R,+I)/(R,-RA(R,+I) (I) 
For computational purposes, R, equals lo7 when there 
is no analyte contribution to the analog quantitation 
ion signal, and R, equals 10P6 when there is no 
analog contribution to the analyte quantitation ion. For 
each analyte, a calibration curve in standard water 
solutions was made by using a five-point curve of 
standard concentration versus RR/(sample weight). In 
each case the curve was linear over the range of 
expected results, and its slope was used in calculating 
the unknown concentration, C, by the equation 
C = (RR)/(slope of calibration curve)(sample weight) 
(2) 
The detection limit of each analyte was determined 
from a plot of the standard deviation of the calculated 
concentration versus the known standard concen- 
tration, using established procedures [26, 271. The y- 
intercept, S, , of the best least squares linear fit is 
determined; this is the standard deviation at zero con- 
centration. The detection limit is 3 times S, and the 
quantitation limit for reporting results is 7 times S,. 
Comparison of Nominal and Accurate Mass Data 
for Quantitation 
The use of a magnetic sector mass spectrometer at 
even the medium resolving power of 3000 has signifi- 
cant advantages over the nominal (integer) mass re- 
solving power of a quadrupole mass spectrometer. 
Previous work using quadrupole instruments achieved 
detection limits for VOCs in human blood in the parts 
per billion to high parts per trillion range. Our method 
using a magnetic sector mass spectrometer has 
achieved detection limits in the low parts per trillion 
range for most target VOCs in a lo-mL sample of 
whole blood. The use of higher mass resolution to 
eliminate interferences from coeluting compounds 
(seen at nominal mass resolution) can be demonstrated 
for methylene chloride, chloroform, and 1’3C31acetone 
in Figures 1, 2, and 3, respectively, for a 9.59-g sample 
of whole human blood from the NHANES III study. 
For this blood sample, the concentrations of chloro- 
form and [‘3C,]acetone were 110 ppt and 10 ppb, 
respectively; the level of methylene chloride is at the 
background level of 80 ppt present in the vacutainer 
itself. In Figures 1, 2, and 3 the accurate mass chro- 
matograms at 3000 resolution were constructed from 
the full-scan data using the appropriate accurate mass 
of the quantitation ion with a limited mass window of 
0.03 Da; and the nominal (integer) mass chro 
matograms were constructed from the full scan data 
using the appropriate integral mass of the quantitation 
ion with the default unit mass window. The quanti- 
tation ions of methylene chloride (CHi5C1i; m/z 
83.9534), chloroform (CH35C1:, m/z %X9455), and 
[13C,]acetone (?,H,O’; m/z 61.0519) are fully re- 
solved at 3000 resolution from other coeluting ions 
with the same nominal (integer) mass. The coeluting 
ions interfering at nominal mass resolution with meth- 
ylene chloride, chloroform, and [13C,lacetone are, re- 
spectively, C,H:; (m/z 84.0939), C,H& (m/z 83.0861), 
and C2H5St (m/z 61.0112). In fact less than 3000 
5:43 5:54 6:05 6:16 
Time (rnin:sec) 
Figure 1. Single-mass chromatograms for methylene chloride 
from a blood sample (9.59 g): (a) nominal mass curve for m/z 84; 
(b) accurate mass curve for CH,Cl: (m/z 83.953 with a window 
of 0.03). 
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8:51 9:02 9:13 
Time (min:sec) 
Figure 2. Single-mass chromatograms for chloroform from a 
blood sample (9.59 g): (a) nominal ma55 curve for m/z 83; 01) 
accurate n&s cur&for CHCl; (m/z 82.945 with a window of 
0.03). 
resolution would be required to separate these ana- 
lytes’ quantitation ions from their interfering ions: 600 
resolution for methylene chloride and chloroform; 1500 
resolution for [‘3C,]acetone. The point of these figures 
is that accurate quantitation for these VOCs in blood at 
low parts per trillion levels is not possible with the 
nominal (integer) mass resoultion of a quadrupole 
mass spectrometer. In various blood samples we have 
examined, the relative amounts of the interfering ions 
vary greatly from sample to sample from the relatively 
low levels seen in Figures 1,2, and 3 from this particu- 
lar blood sample to levels up to 5 to 10 times higher 
such that the signals for the quantitation ions are 
0 
4x59 504 510 516 
Time (min:sec) 
Figure 3. Single-mass chromatograms for [‘“CBlacetone from a 
blood sample (9.59 g): (a) nominal mass curve for nr/s 61; (b) 
accurate rna~~ curve for (‘“CH3)i3CO+ (m/z 67.052 with a 
window of 0.03); (c) accurate rna~~ curve for CZHSS+ (m/z 
61.011 with a window of 0.03). 
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completely masked in the nominal (integer) mass chro- 
matogram by the interfering ions. 
The advantage of accurate mass data (at 3000 reso- 
lution) over nominal (integer) mass data can be 
demonstrated for the quantitation of six analytes, 
which, at nominal (integer) mass, involve significant 
interferences in blood and serum, Using nominal (in- 
teger) mass data, the native mass ratio, R,, and label 
mass ratio, R,, of each analyte are the following (ana- 
lyte CR,, R,)): chloroform ~29.17,0.1671), acetone (107, 
0.005970), methylene chloride (34.43,0.1002), 1,1,2-t& 
chloroethane (15.58, lo-‘), 1,1,2,2-tetrachloroethane 
(35.41,0.09271), trans-1,2-dichloroethene (60.25,0.1544). 
Using accurate mass data, these ratios are the follow- 
ing (analyte (R,, R,)): chloroform 29.38,0.08864), ace- 
tone (761.7, 0.004151), methylene chloride (33.55, 
0.08873), 1,1,2-trichloroethane (27.06, 10m6), 1,1,2,2- 
tetrachloroethane (35.03, 0.04799), truns-1,2-dichlore 
ethene (107,10K6). Using these mass ratios, standard 
calibration curves can be prepared for these six ana- 
lytes in water by using a five-point curve of standard 
concentration versus relative response factor divided 
by sample weight. Table 4 summarizes the standard 
calibration curves of these analytes in water; the curves 
are linear oirer their expected ranges in blood and 
serum (analyte, concentration range): (chloroform, 
10&2000 ppt), (acetone, 100-3000 ppb), (methylene 
chloride, lo-800 ppt), (1,1,2-trichloroethane, lo-1500 
ppt), (1,1,2,2-tetrachloroethane, 10-1000 ppt), (truns- 
1,2-dichloroethene, 10-2000 ppt). The small slope value 
0.00021 for acetone results from its great water solubil- 
ity which produces a low recovery of the acetone from 
water by helium purging. Significant interference from 
coeluting compounds even in standard water solutions 
was fuund as reflected by the size of the difference in 
slope ‘between nominal (integer) and accurate mass 
calibration curves (analyte, slope difference): (1,1,2-W 
chloroethane, 0.4541, (truns-1,2-dichloroethene, 0.1041, 
(chloroform, 0.095), (1,1,2,Ztetrachloroethane, - 0.044). 
This interference comes from the background levels of 
interfering ions from both the water and the purge and 
trap apparatus. 
The effect of nominal (integer) and accurate mass 
data.on the quantitation of these six analytes in blood 
and in the quality control serum are summarized in 
Table 5 for six samples of blood and six samples each 
of two levels of spiked quality control serum (QC-high 
and QC-mid). For each six-sample set Table 5 shows 
for each analyte the mean concentration difference in 
parts per billion between pairs of accurate A, and 
nominal N, mass data: IZC~C(A, - Ni), where n is the 
number of pairs. A paired-comparison t-test was run 
on the corresponding sets of accurate and nominal 
mass data to determine if the difference in concentra- 
tion was statistically different from zero. The differ- 
ence between two sets of measurements is not signifi- 
cantly different from zero if the probability of the 
paired t-distribution has a value greater than 0.05, 
which was found to be the case for only 1,1,2,2-tetra- 
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Table 4. Linear calibration curves in standard water solutions 
Target VOCs 
Nominal mass data 
Slope f 
Intercept standard error 
Accurate mass dataa 
Slope f 
Intercept standard error 
1,1.2.2-Tetrachloroethane -0.0128 0.7799 * 0.0279 - 0.0105 0.8241 + 0.0312 
1.1 ,I-Trichloroethane - 0.0075 1.6316 + 0.1139 ~ 0.0177 1.1779 f 0.0164 
Acetone -0.0013 0.00021 f 0.00001 0.0012 0.00021 + 0.00001 
Chloroform 0.0501 0.9216 f 0.0433 0.0482 1.0169 k 0.0416 
methylene chloride 0.0121 0.1797 f 0.0033 0.0125 0.1834 f 0.0032 
vans-1,2-Dichloroethene -0.0104 1.3636 + 0.0342 0.0242 1.2592 f 0.0310 
‘Accurate value used for the quantitation ions is the theoretical mass-to-charge ratio with a window 
of 0.03. 
chloroethane in serum. The mean pair difference was 
statistically different from zero in the other cases of the 
measured analytes in Table 5. Both the magnitudes of 
the mean pair difference and the corresponding stand- 
ard error in this mean determine the value of the 
paired t-test: the smaller the mean pair difference and 
the larger the corresponding standard error relative to 
the mean pair difference, the larger the value of the 
paired t-test. The mean pair difference is effectively 
zero for 1,1,&Z-tetrachloroethane in the sets of quality 
control serum because the interfering compounds have 
been effectively eliminated by the helium purging per- 
formed before spiking; the value of the paired t-test is 
greater than 0.1 in the serum, which indicates that the 
mean pair difference is statistically zero. 
In Table 5, the magnitude of the relative error in the 
calculated concentration incurred by using nominal 
mass data is indicated by the mean relative percent 
difference: lOOn_‘C[( Ai - NJ/Ail. The levels of inter- 
fering compounds in whole blood were much higher 
than those in the specially prepared quality control 
serum. In the six blood samples, the following analytes 
were below the detection limit (analyte (detection limit 
in ppb)): 1,1,2,2-tetrachloroethane (0.031), frans-1,2- 
dichloroethene (0.024), and 1,1,2-trichloroethane 
(0.027); these analytes are not normally found in blood. 
Table 5. Comparison of accurate and nominal mass data for quantitation of VOCs in blood 
and quality control serum (QC-high and QC-mid) 
Mean concentration differenceof 
accurate Ai & nominal N; pairs 
n-%A; - Nil Mean relative Paired t-test 
Target VOCs Sample(n) f std error Ippb) difference(%)” prob > ItI 
1 ,1,2,2-Tetrachloroethane Blood 16) -0.2178 + 0.0437 b 0.0042 
QC-high (6) -0.0082 f 0.0042 -3.52 0.104 
QC-mid (6) -0.0019 f 0.0011 -1.61 0.148 
1 ,1.2-Trichloroethane Blood (61 -0.0658 + 0.0068 b 0.0002 
QC-high (6) 0.0297 f 0.0102 10.25 0.0333 
QC-mid (61 0.0274 f 0.0067 17.00 0.0098 
Acetone Blood (61 2130 f 1476 38.95 c 
QC-high (6) 7.4469 f 0.8432 0.89 0.0003 
QC-mid 16) 10.6853 f 1.6487 1.31 ODD1 3 
Chloroform QC-high (6) -0.1576 f 0.0207 - 5.43 0.0006 
QC-mid (6) -0.0635 f 0.0071 -3.65 0.0003 
Methylene chloride Blood (6) -0.0235 f 0.0063 - 26.52 0.0137 
W-high (6) 0.0127 f 0.0026 0.19 0.0047 
QC-mid (6) -0.0069 + 0.0023 -0.22 0.0276 
bans-l,P-Dichloroethene QC-high (6) 0.0943 f 0.0106 15.02 0.0003 
QC-mid (6) 0.0462 f 0.0018 21.13 0.0001 
a The mean relative percent difkrence is 1 OOn-‘IXfAi-Ni) /A;]. 
bTha analvte is belowthe detection limit in the blood samDIes; the signal seen at nominal mass is all 
from the intkfering ion. 
‘The amount of the interfering ion C,H,S* varied by a factor of 10 among the six blood samples, this 
produced such a wide range (17-68%) of decrease in calculated acetone concentration for nominal 
mass data that the paired t-test for acetone in blood was not significant. 
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The detection limits in blood for acetone, chloroform, 
and methylene chloride are, respectively, 11,0.040, and 
0.080 ppb. At nominal mass, however, significant sig- 
nals from other coeluting compounds from blood were 
found for the quantitation ions of 1,1,2,2-tetrachloro- 
ethane (CH35Clf, m/z E2.9455) and l,l,Z-trichloro- 
ethane (C,Hz5Clf, m/t 96.9612) with the interfering 
ions C,H:, (m/z 83.0861) and C,HF3 (m/z 97.10171, 
respectively. In this case, the nominal mass data pro- 
duced completely erroneous results for the blood sam- 
ples because the signals at nominal mass are all from 
the interfering ions but the signals at accurate mass are 
just the background noise. For trans-1,2-dichloro- 
ethene, no ion is present in the blood or serum to 
interfere with its quantitation ion; the interference oc- 
curs only for its labeled analog’s quantitation ion 
(CzHz7ClC; m/z 64.9941) with the interfering ion 
C,H: (m/z 65.0391); this results in significant errors 
in the calculated concentration if nominal mass data 
arc used (about 15 and 21% less than the actual values 
in the serums QC-high and QC-mid, respectively). 
Significant interference in the blood from the ion C,H& 
(m/z 84.0939) occurred at nominal mass for methylene 
chloride’s quantitation ion CH z”Cl:’ (m/z 83.95341, 
resulting in a concentration value about 27% greater 
than the actual value if nominal mass data are used. 
For the six blood samples examined here, the signal for 
chloroform’s quantitation ion CH”‘C1; (m/z 82.9455) 
at nominal mass was only a shoulder on an intense 
interfering signal from the ion C bH i1 (WI/Z 83.0861); as 
a result, no meaningful area estimation could be made. 
the theoretical masses with a mass window of 0.03 Da 
over the entire GC/MS run. The use of isotope dilu- 
tion mass spectrometry with purge-and-trap analysis 
and detection by a magnetic sector mass spectrometer 
operating in full-scan mode at medium resolution per- 
mits us to achieve detection limits in the low parts per 
trillion range for most target VOCs from a IO-mL 
sample of whole blood. Full-scan data were used in 
this method instead of selected ion recording so that 
analytes not on the current target list of the NHANES 
III survey could be identified in the blood. 
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